BiotechTube

Ondansetron Tablets USP 8 mg + Ondansetron Hydrochloride

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fed

Conditions

Fed

Trial Timeline

May 1, 2011 → Sep 1, 2011

NCT ID
NCT01578265

About Ondansetron Tablets USP 8 mg + Ondansetron Hydrochloride

Ondansetron Tablets USP 8 mg + Ondansetron Hydrochloride is a phase 1 stage product being developed by Ipca Laboratories for Fed. The current trial status is completed. This product is registered under clinical trial identifier NCT01578265. Target conditions include Fed.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT01578252Phase 1Completed
NCT01578265Phase 1Completed

Competing Products

20 competing products in Fed

See all competitors
ProductCompanyStageHype Score
Lamotrigine Tablets 25 mg + LamotrigineIpca LaboratoriesPhase 1
33
Levocetirizine Dihydrochloride tablets 5 mg + Levocetirizine DihydrochlorideIpca LaboratoriesPhase 1
33
Indomethacin Extended-Release Capsules USP 75 mg + Indomethacin Extended Release Capsules USP 75 mgIpca LaboratoriesPhase 1
33
Risperidone Tablet 1 mg + RisperidoneIpca LaboratoriesPhase 1
33
Metoprolol Succinate ER Tablet 200 mg + 'TOPROL-XL®' ER Tablets 200 mgIpca LaboratoriesPhase 1
33
Bisoprolol Fumarate Tablet 10 mg + BisoprololIpca LaboratoriesPhase 1
33
Lisinopril Tablets 40 mg + LisinoprilIpca LaboratoriesPhase 1
33
Quetiapine Fumarate Tablets 25 mg + Quetiapine FumarateIpca LaboratoriesPhase 1
33
Etodolac Tablets USP 500mg + Etodolac Tablets USP 500 mgIpca LaboratoriesPhase 1
33
Lisinopril and Hydrochlorothiazide Tablets (20+25) mg + Zestoretic® 20/25 lisinopril/hydrochlorothiazide TabletsIpca LaboratoriesPhase 1
33
Dapagliflozin/metformin XR 5/500mg + Dapagliflozin/metformin XR 5/500 mg + Dapagliflozin/metformin XR 5/500mg + Dapagliflozin/metformin XR 5/500mg + Dapagliflozin/metformin XR 10/1000mg + Dapagliflozin/metformin XR 10/1000mg + Dapagliflozin/metformin XR 10/1000mg + Dapagliflozin/metformin XR 10/1000mgAstraZenecaPhase 1
33
Pantoprazole SodiumDr. Reddy's LaboratoriesPhase 1
30
DesloratadineDr. Reddy's LaboratoriesPhase 1
30
ReminylDr. Reddy's LaboratoriesPhase 1
30
OlanzapineDr. Reddy's LaboratoriesPhase 1
30
CIPRO®XRDr. Reddy's LaboratoriesPhase 1
30
Olanzapine OD Tablets 5 mgDr. Reddy's LaboratoriesPhase 1
30
Amlodipine Besylate/Benazepril HClDr. Reddy's LaboratoriesPhase 1
30
Mycophenolate MofetilDr. Reddy's LaboratoriesPhase 1
30
DexmethylphenidateCingulatePhase 1
25

Other Products from Ipca Laboratories

Metoprolol Succinate ER Tablets 50 mg + 'TOPROL-XL®' ER Tablets 50 mgPhase 1
33
Indomethacin Extended-Release Capsules USP 75 mg + Indomethacin Extended Release Capsules USP 75 mgPhase 1
33
Etodolac Capsules USP 300 mg + EtodolacPhase 1
33
Risperidone Tablet 1 mg + RisperidonePhase 1
33
Etodolac Capsules USP 300 mg + EtodolacPhase 1
33